These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 3732727

  • 1. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A, Massacci C, Curzi G, Pigini G, Costantini C, Bilancini A, Blandini A.
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [Abstract] [Full Text] [Related]

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 3. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F, Ansalone G, Scabbia E, Santarelli P, Lucente M, Affinito V, Loperfido F, Zecchi P.
    G Ital Cardiol; 1981 May; 11(4):488-97. PubMed ID: 6169580
    [Abstract] [Full Text] [Related]

  • 4. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E, Ferroni C, Marini M, Campanari G.
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
    Hwang YS, Wang JL.
    Clin Ther; 1989 May; 11(3):392-7. PubMed ID: 2743373
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ, Rubenfire M, Blevins RD, Frumin H, Faitel K, Jarandilla R, Aragon E, Marinescu G, Luarca R.
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [Abstract] [Full Text] [Related]

  • 7. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH, Chiale PA, Bandieri JD, Lázzari JO, Elizari MV, Rosenbaum MB.
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [Abstract] [Full Text] [Related]

  • 8. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G, Danzi GB, Austoni P, Fancini P, Mascarello M, Figini A.
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [Abstract] [Full Text] [Related]

  • 9. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL, Lechat P, Frank R, Lascault G, Fontaine G, Facquet J, Cohen A, Grosgogeat Y.
    Ann Cardiol Angeiol (Paris); 1984 Aug; 33(5):309-15. PubMed ID: 6476769
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T, Kasper W, Stengel E, Waldecker B, Löllgen H, Jähnchen E, Bechtold H, Just J.
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
    Nademanee K, Feld G, Hendrickson J, Intarachot V, Yale C, Heng MK, Singh BN.
    Am Heart J; 1985 Nov; 110(5):923-31. PubMed ID: 3904380
    [Abstract] [Full Text] [Related]

  • 13. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects].
    Zacà F, Ghinelli M, Bombardini T, De Collibus C, Zaccaria O, Steffanon L, Azzolini U, Valentini P, Puddu P.
    G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228
    [Abstract] [Full Text] [Related]

  • 14. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L, Carlier J.
    Acta Cardiol Suppl; 1980 Jun; (25):127-35. PubMed ID: 6966452
    [Abstract] [Full Text] [Related]

  • 15. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J, Hidden F, Naditch L, Coutte R, Himbert C, Frank R.
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [Abstract] [Full Text] [Related]

  • 16. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A, Mary-Rabine L, Legrand V, Demoulin JC, Kulbertus HE.
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP.
    Acta Cardiol Suppl; 1980 Dec; (25):121-5. PubMed ID: 6990664
    [Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF, Morganroth J.
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.